注册 登录  
 加关注
   显示下一条  |  关闭
温馨提示!由于新浪微博认证机制调整,您的新浪微博帐号绑定已过期,请重新绑定!立即重新绑定新浪微博》  |  关闭

liusongjifan2的博客

读书是同智者交流;读书是对神奇世界的探访;读书是和挚友娓娓谈心 !

 
 
 

日志

 
 

【转载】The Lancet Oncology  

2016-04-29 09:20:17|  分类: 医学知识 |  标签: |举报 |字号 订阅

  下载LOFTER 我的照片书  |

Vol.17

Number 5 | May 2016

p 539?-?680 | e173?-?e219

My AccountSubscribe NowAuthorsAbout UsPodcasts
TweetShare on Facebook

Editor's Choice

Satellite view of Europe — Copyright: Planetobserver/Science Photo Library

Editorial: The impact of Brexit on cancer care and research. In this issue of The Lancet Oncology, prominent oncologists from both the EU and the UK voice their support for the UK remaining part of the EU. In so doing, they join other scientists and clinicians who have publicly declared their belief that it would be best to remain.

Read this article

Pregnant lady holding up pregnancy scan — Copyright: Ian Hooton/Science Photo Library

Article: Likelihood of pregnancy or siring a child in survivors of childhood cancer. A new study aims to establish the effects of chemotherapeutic drugs on pregnancy in male and female survivors of childhood cancer not exposed to pelvic or cranial radiotherapy.

Read this article

EDITORIAL
Impact of Brexit on cancer care and research 
Improved drug access in low and middle-income countries 
COMMENT
Chemotherapy risks to fertility of childhood cancer survivors 
Tyrosine kinase inhibitors as first-line treatment in NSCLC 
Lung cancer CT screening: is annual screening necessary? 
Inflammatory breast cancer: a new approach 
Ponatinib for chronic myeloid leukaemia: future perspectives 
Dual inhibition of oncogenic targets for B-cell malignancies 
Pazopanib for both GIST and soft-tissue sarcoma 
Targeted therapy in BRAF-mutated lung adenocarcinoma 
Targeting macrophages to treat pancreatic cancer 
Time for better presentation and analysis of adverse events 
Nominal nomograms and marginal margins: what is the law of the line? 
The EU: what's best for UK cancer research and patients? 
Brexit: a European perspective 
Beyond a moonshot: insurance coverage for proton therapy 
CORRESPONDENCE
Proton beam therapy for medulloblastoma 
Proton beam therapy for medulloblastoma 
Proton beam therapy for medulloblastoma 
Proton beam therapy for medulloblastoma – Author's reply 
Neratinib after trastuzumab in patients with HER2-positive breast cancer 
Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply 
Justifying vein resection with pancreatoduodenectomy 
Justifying vein resection with pancreatoduodenectomy – Author's reply 
The US Cancer Moonshot initiative 
CORRECTIONS
NEWS
CANCER AND SOCIETY
ARTICLES
REVIEW
POLICY REVIEW

Online First

April 27, 2016

Post-operative survival of patients with lung cancer

April 27, 2016

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
【转载】The Lancet Oncology - liusongjifan2 - liusongjifan2的博客

You are receiving this email because you subscribed to TheLancet.com alerting service.

This email has been sent from The Lancet, Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, registered in England with registered number 1982084.

Update Mailing Preferences to unsubscribe from The Lancet Oncology eTOC alerts. For all other queries please contact custserv@lancet.com.

Privacy Policy

Copyright ? 2016 Elsevier Limited except certain content provided by third parties. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.

  评论这张
 
阅读(4)| 评论(0)
推荐 转载

历史上的今天

在LOFTER的更多文章

评论

<#--最新日志,群博日志--> <#--推荐日志--> <#--引用记录--> <#--博主推荐--> <#--随机阅读--> <#--首页推荐--> <#--历史上的今天--> <#--被推荐日志--> <#--上一篇,下一篇--> <#-- 热度 --> <#-- 网易新闻广告 --> <#--右边模块结构--> <#--评论模块结构--> <#--引用模块结构--> <#--博主发起的投票-->
 
 
 
 
 
 
 
 
 
 
 
 
 
 

页脚

网易公司版权所有 ©1997-2017